OSTERTAG ERIC (Chief Executive Officer) sold 0.6% of their position (20.03K shares) of POSEIDA THERAPEUTICS, INC. on the open market
Open‑market sale worth $140.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/5/2021ACC: 0001209191-21-059651
DirectorOfficer10% Owner· Chief Executive Officer
Since Jul 2020
-20.03K
Net shares
Net seller
$140.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
20.03K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−10.45K
Price / share
$7.02
Trade value
$73.36K
% of position
0.3%
10/1/2021
3.68M→3.67M
Common Stock
Indirect
Shares
−9.58K
Price / share
$7.02
Trade value
$67.24K
% of position
0.3%
10/1/2021
3.38M→3.37M
Total
Net shares
−20.03K
Net value
-$140.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/1/2021 | S · Sale | −10.45K | $7.02 | $73.36K | 0.3% | 3.68M | 3.67M |
| Common Stock Indirect | 10/1/2021 | S · Sale | −9.58K | $7.02 | $67.24K | 0.3% | 3.38M | 3.37M |
| Total | −20.03K | -$140.60K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned629.19K
Common Stock
IndirectShares owned160.70K
Common Stock
DirectShares owned675.41K
Common Stock
IndirectShares owned961.45K
Total
675.41K direct·1.75M indirect2.43M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 629.19K | Indirect |
| Common Stock | 160.70K | Indirect |
| Common Stock | 675.41K | Direct |
| Common Stock | 961.45K | Indirect |
| Total | 2.43M | 675.41K direct·1.75M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported